V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20213555 | 20129370 | 1.66 | 83.1 | Neo-adjuvant (N) | 2020-01-06 | 2020-01-19 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101622761 |
| 20213556 | 20129371 | 1.49 | 69.35 | Neo-adjuvant (N) | null | 2017-04-17 | Trial Unspecified | 02 | Y | TRIAL | 101404033 |
| 20213557 | 20129372 | 1.6 | 81 | null | 2019-05-21 | 2019-06-04 | EOX | 02 | null | TRIAL | 101480499 |
| 20213558 | 20129373 | 1.87 | 74.2 | Palliative (P) | 2019-09-25 | 2019-10-20 | IRINOTECAN + MDG + PANITUMUMAB | null | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100968830 |
| 20213561 | 20129374 | 1.84 | 73.9 | Palliative (P) | 2016-11-23 | 2016-12-07 | EOX | N | N | EOX | 100968001 |
| 20213563 | 20129375 | 1.6 | 71 | Palliative (P) | 2018-09-01 | 2018-09-01 | Capecitabine 42days + RT | N | N | CAPECITABINE + RT | 100382590 |
| 20213565 | 20129376 | 1.67 | 87 | Palliative (P) | 2018-03-14 | 2018-03-14 | EOX | N | N | EOX | 100332817 |
| 20213566 | 20129377 | 1.72 | 49.9 | null | 2019-11-04 | 2019-11-04 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 101311290 |
| 20213567 | 20129378 | 1.6 | 74 | Adjuvant (A) | 2018-06-19 | 2018-06-20 | EOX | 02 | N | TRIAL | 100590211 |
| 20213569 | 20129379 | 1.63 | 77.4 | Curative (C) | 2016-11-20 | 2016-11-20 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101179801 |
| 20213571 | 20129380 | 1.6 | 80 | Neo-adjuvant (N) | 2017-08-31 | 2017-08-31 | EOX | 02 | null | EOX | 101061953 |
| 20213572 | 20129381 | 1.74 | 78 | Palliative (P) | 2018-09-13 | 2018-10-08 | Sorafenib | 02 | N | SORAFENIB | 101261920 |
| 20213573 | 20129382 | 1.58 | 65 | null | 2017-01-26 | 2018-01-02 | EOX | 02 | Y | EOX | 101580813 |
| 20213574 | 20129383 | 1.7 | 58.8 | Neo-adjuvant (N) | 2019-02-13 | 2019-02-13 | EOX | 02 | n | SORAFENIB | 100168456 |
| 20213575 | 20129384 | 1.65 | 73.7 | Palliative (P) | 2018-04-10 | 2018-06-20 | EOX | 02 | N | SORAFENIB | 100186875 |
| 20213576 | 20129385 | 1.78 | 96.2 | Neo-adjuvant (N) | 2020-10-30 | 2020-11-05 | EOX | 02 | N | SORAFENIB | 101242007 |
| 20213577 | 20129386 | 1.6 | 83.8 | null | 2017-04-14 | 2017-04-15 | GO2 TRIAL | 02 | Y | TRIAL | 100439753 |
| 20213579 | 20129387 | 1.75 | 88.2 | Neo-adjuvant (N) | 2017-09-03 | 2017-09-17 | Sorafenib | 02 | N | SORAFENIB | 100461810 |
| 20213583 | 20129388 | 1.9 | 58.1 | Palliative (P) | 2019-02-18 | 2019-02-23 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 100017394 |
| 20213588 | 20129389 | 1.42 | 59.6 | null | 2016-04-12 | 2016-04-14 | EOX | 02 | N | EOX | 101389086 |
| 20213589 | 20129390 | 1.63 | 82 | Disease modification (D) | 2019-01-30 | 2019-02-13 | EOX | N | Y | EOX | 100368827 |
| 20213591 | 20129391 | 1.63 | 106.6 | Palliative (P) | 2016-10-16 | 2017-02-21 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100592337 |
| 20213592 | 20129392 | 1.76 | 56.1 | Palliative (P) | 2020-01-17 | 2020-01-20 | EOX | 2 | null | EOX | 100327698 |
| 20213594 | 20129393 | 1.9 | 97.6 | Palliative (P) | 2017-04-15 | 2017-05-02 | Panitumumab + Irinotecan + MdG | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100013005 |
| 20213595 | 20129394 | 1.71 | 0 | Palliative (P) | null | 2018-06-20 | CETUXIMAB + OXALIPLATIN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101336991 |
| 20213597 | 20129395 | 1.49 | 95 | Palliative (P) | 2015-08-11 | 2015-09-08 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101514056 |
| 20213598 | 20129396 | 1.56 | 83.8 | Adjuvant (A) | 2020-03-05 | 2020-03-20 | Trial Unspecified | 1 | N | TRIAL | 100783929 |
| 20213599 | 20129397 | 1.92 | 65.1 | Palliative (P) | 2017-12-09 | 2019-07-04 | Sorafenib | 1 | N | SORAFENIB | 100901097 |
| 20213602 | 20129398 | null | 80.8 | Adjuvant (A) | 2017-03-12 | 2017-04-01 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100019214 |
| 20213603 | 20129399 | 1.82 | 70.8 | Palliative (P) | 2016-08-26 | 2016-09-07 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100862349 |
| 20213605 | 20129400 | 1.66 | 78.8 | Palliative (P) | 2018-01-25 | 2018-02-22 | Capecitabine 5days + RT | 02 | Y | CAPECITABINE + RT | 101414041 |
| 20213607 | 20129401 | 1.64 | 84.35 | Curative (C) | 2019-10-09 | 2019-10-20 | EOX | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100741820 |
| 20213609 | 20129402 | 1.6 | null | null | 2018-05-16 | 2018-09-26 | Trial Unspecified | 2 | null | TRIAL | 101836650 |
| 20213613 | 20129403 | 1.72 | 74.7 | Adjuvant (A) | 2017-08-08 | 2017-09-19 | Capecitabine 42days + RT | 02 | N | CAPECITABINE + RT | 100037530 |
| 20213614 | 20129404 | 1.63 | 82.65 | null | 2019-08-18 | 2019-08-19 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101670283 |
| 20213616 | 20129405 | 1.75 | 59.5 | Palliative (P) | 2019-07-09 | 2019-10-24 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100809040 |
| 20213617 | 20129406 | 1.66 | 82.25 | 03 | 2018-06-05 | 2019-07-26 | EOX | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101858310 |
| 20213618 | 20129407 | 1.7 | null | Palliative (P) | 2021-08-04 | 2021-08-04 | EOX | 02 | null | EOX | 100748019 |
| 20213619 | 20129408 | 1.78 | 84.4 | Neo-adjuvant (N) | 2015-12-16 | 2016-05-27 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101355491 |
| 20213622 | 20129409 | 1.78 | 67.1 | Palliative (P) | 2018-02-20 | 2018-09-25 | EOX | 02 | N | EOX | 100456411 |
| 20213626 | 20129410 | 1.71 | 76.4 | Palliative (P) | 2017-09-02 | 2017-09-03 | EOX | N | N | EOX | 101843820 |
| 20213627 | 20129411 | 1.64 | 85 | Palliative (P) | 2017-08-02 | 2017-08-22 | EOX | 02 | N | SORAFENIB | 101869127 |
| 20213629 | 20129412 | 1.71 | 64 | Palliative (P) | 2021-11-16 | 2021-12-11 | Sorafenib | 02 | Y | SORAFENIB | 101779797 |
| 20213630 | 20129413 | 1.76 | 82 | Adjuvant (A) | 2018-01-13 | 2018-01-20 | EOX | 01 | N | TRIAL | 101757802 |
| 20213637 | 20129414 | 1.81 | 71.7 | null | 2020-09-22 | 2020-10-14 | Trial Unspecified | N | Y | TRIAL | 101482257 |
| 20213639 | 20129415 | 1.61 | 81.7 | Curative (C) | 2017-02-18 | 2017-02-26 | Capecitabine 35days + RT | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100073221 |
| 20213640 | 20129416 | 0 | 51 | Palliative (P) | 2019-01-19 | 2019-02-09 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101465917 |
| 20213641 | 20129417 | 1.79 | 61.3 | null | 2016-06-20 | 2016-09-11 | EOX | 2 | null | TRIAL | 100082249 |
| 20213644 | 20129418 | 1.62 | 92.7 | Adjuvant (A) | 2019-06-16 | 2019-06-28 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100689188 |
| 20213645 | 20129419 | 1.6 | 62 | null | 2019-08-16 | 2019-08-16 | Cetuximab + Oxaliplatin + MdG Maint | 01 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101287695 |